About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 585 record(s)
Req # A-2019-002029
Adverse Reaction Report (AER). Report number: 000732990.Organization: Health Canada
July 2020
Req # A-2019-002068
Adverse Reaction Report (AER) for TECTA. Report numbers: E2B_02885410, E2B_02872807.Organization: Health Canada
July 2020
Req # A-2019-002077
Adverse Reaction Report (AER). Report number: E2B_02693798.Organization: Health Canada
July 2020
Req # A-2019-002084
Adverse Reaction Report (AER). Report number: E2B_02693038.Organization: Health Canada
July 2020
Req # A-2020-000014
Adverse Reaction Report (AER) for ZOLPIDEM TARTRATE. Report numbers: 721499, E2B_02082409, E2B_02263739.Organization: Health Canada
July 2020
Req # A-2020-000049
Adverse Reaction Report (AER) for DEXILANT. Report numbers: 000910325, E2B_02932101, E2B_02946406, E2B_02954989, E2B_02981227.Organization: Health Canada
July 2020
Req # A-2020-000056
Adverse Reaction Report (AER) for PANTOPRAZOLE MAGNESIUM. Report numbers: 735204, E2B_02946358.Organization: Health Canada
July 2020
Req # A-2020-000066
Adverse Reaction Report (AER) for ANTI-THYMOCYTE GLOBULIN (RABBIT). Report numbers: E2B_02564415, E2B_02564522, E2B_02567164, E2B_02564513, E2B_02567215, E2B_02564869, E2B_02565020, E2B_02564929, E2B_025648+C29:C3363, E2B_02565199, E2B_02564584, E2B_02565208, E2B_02564583, E2B_02567072, E2B_02564554, E2B_02565143, E2B_02567085, E2B_02564535, E2B_02567087, E2B_02610152.Organization: Health Canada
July 2020
Req # A-2020-000070
Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02655367, E2B_02564318, E2B_02590882, E2B_02542374, E2B_02546157, E2B_02549592, E2B_02549861, E2B_02561169, E2B_02561355, E2B_02589105, 000724948, E2B_02494146, E2B_02496560, 000727575, E2B_02495950, 000727310, E2B_02493939, E2B_02526409, E2B_02598262, E2B_02600159.Organization: Health Canada
July 2020
Req # A-2020-000071
Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02606418, E2B_02608012, E2B_02607127, E2B_02613556, E2B_02578626, E2B_02585269, E2B_02642108, E2 B_02643457, E2B_02643564, E2B_02645077, E2B_01361047, E2B_00778650, E2B_02646748, E2B_02647498, E2B_00481009, E2B_00495172, E2B_00481009, E2B_00481009, 000724367, E2B_02562487.Organization: Health Canada
July 2020